NDC codes

FDA NDC Directory
Product NDC (as listed)71205-243Labeler and product segments. Claims need a package NDC.
Product NDC at billing width71205-0243Add the package segment from the table below.
Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC11-digit (billing)PackageCopy
71205-243-307120502433030 CAPSULE in 1 BOTTLE (71205-243-30)Marketed from Mar 1, 2019
71205-243-607120502436060 CAPSULE in 1 BOTTLE (71205-243-60)Marketed from Mar 1, 2019
71205-243-907120502439090 CAPSULE in 1 BOTTLE (71205-243-90)Marketed from Mar 1, 2019

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary)
Acyclovir
Generic name (nonproprietary)
acyclovir
Active ingredients
Acyclovir — 200 mg/1
Dosage form
Capsule
Route
Oral
Product type
Prescription drug
Marketing category
ANDA — Abbreviated New Drug Application (generic)Application ANDA 075677
Marketing start
Listing expires
Other FDA classes
DNA Polymerase Inhibitors (Mechanism)Nucleoside Analog (EXT)
Identifiers
Product ID 71205-243_c225060d-b6e8-4343-8e4d-b52067f05792SPL ID c225060d-b6e8-4343-8e4d-b52067f05792SPL set ID 8d7994a6-5bd2-494d-89c1-b03755d4f2c3RxCUI 197310UNII X4HES1O11F
Pharmacologic class
Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor; Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N471205024330 followed by a unit qualifier and the quantity

Package 71205-0243-30. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective .

Indications (excerpt from the label)

INDICATIONS AND USAGE Herpes Zoster Infections Acyclovir capsule is indicated for the acute treatment of herpes zoster (shingles). Genital Herpes Acyclovir capsule is indicated for the treatment of initial episodes and the management of recurrent episodes of genital herpes. Chickenpox Acyclovir capsule is indicated for the treatment of chickenpox (varicella).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 075677

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 075677
ProductStrengthForm · routeLabelerProduct NDC
AcyclovirAcyclovir 200 mg/1CapsuleOralBryant Ranch Prepack72162-1704
AcyclovirAcyclovir 200 mg/1CapsuleOralBryant Ranch Prepack71335-0470
AcyclovirAcyclovir 200 mg/1CapsuleOralApotex Corp.60505-0042

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free Med-Code account to keep looking up NDCs, J-codes and drugs.

Create a free accountLog in